Transparency in clinical trial reporting

Paula A Rochon^{1

2}, Nathan M Stall^{1

2}, Rachel D Savage¹, An-Wen Chan^{1

3}

Affiliations

¹ Women's College Research Institute, Women's College Hospital, Toronto, ON, Canada.
² Division of Geriatric Medicine, Department of Medicine, University of Toronto, ON, Canada.
³ Division of Dermatology, Department of Medicine, University of Toronto, Toronto, ON, Canada.

Editorial

Paula A Rochon et al. BMJ. 2018.

. 2018 Oct 9:363:k4224.

doi: 10.1136/bmj.k4224.

Paula A Rochon^{1

2}, Nathan M Stall^{1

2}, Rachel D Savage¹, An-Wen Chan^{1

3}

¹ Women's College Research Institute, Women's College Hospital, Toronto, ON, Canada.
² Division of Geriatric Medicine, Department of Medicine, University of Toronto, ON, Canada.
³ Division of Dermatology, Department of Medicine, University of Toronto, Toronto, ON, Canada.

No abstract available

Conflict of interest statement

Competing interests: We have read and understood the BMJ Group policy on declaration of interests and declare the following interests: none.

Collaboration between academics and industry in clinical trials: cross sectional study of publications and survey of lead academic authors.
Rasmussen K, Bero L, Redberg R, Gøtzsche PC, Lundh A. Rasmussen K, et al. BMJ. 2018 Oct 3;363:k3654. doi: 10.1136/bmj.k3654. BMJ. 2018. PMID: 30282703 Free PMC article.